Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

THE TWO-STAGE STANDARD: TECHNIQUES, TIMING AND STATISTICS

The Current Concepts in Joint Replacement (CCJR) Winter Meeting, 14 – 17 December 2016.



Abstract

Two-stage treatment of chronically infected TKA is the most common form of management in North America and most parts of the world. One-stage management has pros and cons which will not be discussed in this lecture.

There is great variation of techniques and timing and little data to definitively support one technique or timing approach vs. another. Most methods are based on empirical success and logic. At the time of surgery, the first step is removal of infected implants. All metallic implants and cement should be removed. The most common places to leave cement behind inadvertently include patellar lug holes, femoral lug holes, and the anterior proximal tibia behind the tibial tubercle. Formal synovectomy should be performed. The next step is typically antibiotic-impregnated spacer placement. There are pros and cons of dynamic and static spacers with no clear evidence of superiority of one vs. another. Dynamic spacers work satisfactorily with mild to moderate bone loss, but more severe bone loss is usually better treated with static spacers and a cast. Most antibiotic spacers are made of methyl methacrylate cement with addition of high-dose antibiotics. In most cases, doses of 4–8 gm of antibiotics per pack of cement are preferred. The type of dosing depends on the specific antibiotic and the type of cement used. The most common antibiotics used are vancomycin and gentamycin. When the femoral canals have been instrumented, antibiotic-impregnated cement wands are usually placed in the medullary canal, as the medullary canals have been shown to have high risk of residual bacteria being present.

The resection interval may vary and there is no clear evidence of a “best” resection interval. Practically speaking, most surgeons use a resection period of 8–16 weeks depending on the type of spacer utilised. During the resection interval, serum markers (ESR and CRP) are followed periodically. One anticipates a decline or normalization of these parameters prior to second stage reimplantation procedure. There has not been a demonstrated advantage to reaspiration of the knee before reimplantation in most circumstances.

At the time of reimplantation, the spacers are removed and the knee is redebrided. The key at the time of reimplantation is to obtain good implant fixation but to also balance this with the potential for manageable extraction of the implants at some later date. Good implant fixation is important because failure rates due to mechanical failure are approximately equal to those of failure due to reinfection by 10 years. It is important to remember that reinfection risk is at least 10% by ten years, and therefore extractability of implants is also important. Post-operative management typically includes IV antibiotics, followed by oral antibiotics until final intra-operative cultures are available.

The results of two-stage reimplantation are reported in many series. Most show approximately 85–95% rate of successful eradication of infection in the first five years. Reinfections, often with different organisms, may occur even late after reimplantation. By ten years after surgery survival free of mechanical failure and infection in most series drops to 80% or less due to recurrent infections and mechanical failures.